Skip to main content

Carrie Mendivil

Head of Investor Relations

Adaptive Biotechnologies Corp (ADPT)

Head of Investor Relations

10x Genomics, Inc. (TXG)

Head of Investor Relations

Guardant Health, Inc. (GH)

Head of Investor Relations

908 Devices Inc. (MASS)

Head of Investor Relations

Seer, Inc. (SEER)

Head of Investor Relations

Nautilus Biotechnology, Inc. (NAUT)

Head of Investor Relations

Ginkgo Bioworks Holdings, Inc. (DNA)

Head of Investor Relations

SI-BONE, Inc. (SIBN)

Equibles does not estimate personal net worth.

Get an email with a short summary when Adaptive Biotechnologies Corp publishes a filing, an earnings call transcript or a press release.

Get ADPT alerts

About Carrie Mendivil

Carrie Mendivil is recorded as Head of Investor Relations at Adaptive Biotechnologies Corp (ADPT), Head of Investor Relations at 10x Genomics, Inc. (TXG), Head of Investor Relations at Guardant Health, Inc. (GH), Head of Investor Relations at Pacific Biosciences Of California, Inc. (PACB), Head of Investor Relations at 908 Devices Inc. (MASS), Head of Investor Relations at Seer, Inc. (SEER), Head of Investor Relations at Nautilus Biotechnology, Inc. (NAUT), Head of Investor Relations at Ginkgo Bioworks Holdings, Inc. (DNA) and Head of Investor Relations at SI-BONE, Inc. (SIBN). Carrie Mendivil has spoken on 29 earnings calls across 4 companies, most recently for Seer, Inc. on February 27, 2025. Those appearances were for Seer, Inc. (SEER), Guardant Health, Inc. (GH), Nautilus Biotechnology, Inc. (NAUT) and 908 Devices Inc. (MASS). Seer, Inc. is classified in the Biotechnology industry within the Healthcare sector. Guardant Health, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Seer, Inc. includes Omid Farokhzad (CEO and Board Member), Charles Endweiss (CFO and Chief Accounting Officer), Elona Kogan (General Counsel) and 7 others.

Carrie Mendivil on recent calls

“Earlier today, Seer released financial results for the quarter and year ended December 31, 2024.”
Head of Investor Relations, Seer, Inc. Q4 FY2024 Earnings Call ·
“Earlier today, Seer released financial results for the quarter ended September 30, 2024.”
Head of Investor Relations, Seer, Inc. Q3 FY2024 Earnings Call ·
“Earlier today, Seer released financial results for the quarter ended June 30, 2024.”
Head of Investor Relations, Seer, Inc. Q2 FY2024 Earnings Call ·
“Earlier today, Seer released financial results for the quarter ended March 31, 2024.”
Head of Investor Relations, Seer, Inc. Q1 FY2024 Earnings Call ·
“Earlier today, Seer released financial results for the quarter and year ended December 31, 2023.”
Head of Investor Relations, Seer, Inc. Q4 FY2023 Earnings Call ·

Affiliation history

Company network

Current role

Medical Devices · Healthcare

Head of Investor Relations

Leadership on record at Seer, Inc.

Leadership on record at Guardant Health, Inc.

Leadership on record at Nautilus Biotechnology, Inc.

Recent activity

Show 17 earlier activities